This contract expires in 166 days (Sep 30, 2026).
FIRM FIXED PRICENO SET ASIDE USED.
SOFIE CO. - RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT
PIID: HT009026FG1210062
Signed Date: Dec 2, 2025Effective Date: Dec 2, 2025End Date: Closes in 166 days
Key Details
Description
RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT
Contractor Information
Similar Awards
LUTATHERA AND PLUVICTO
NOVARTIS PHARMACEUTICALS CORPORATION
$3.2M
8511784063!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC.
$2.0M
8511784064!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC.
$1.3M
4569692252!RSDL
CANADIAN COMMERCIAL CORPORATION
$747,796
8511784112!ADENOVIRUS TYPE 4 A
TEVA PHARMACEUTICALS USA, INC.
$660,627.72
Stay Updated
Get notified about new opportunities matching your interests.
Related
Agencies
Vendors